HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer.

AbstractBACKGROUND AND OBJECTIVES:
Despite its dwindling occurrence, gastric cancer remains a leading cause of cancer related mortality worldwide. Molecular determinants of prognosis that impact survival are being sought out as a means to facilitate rational clinical decision-making and enhance patient management. In this study, we evaluated three molecules implicated in gastric carcinogenesis and demonstrated that the differential expression of cyclooxygenase-2 (COX-2) and the viral oncogene homolog Src proteins could explain the differences in survival observed in patients older and younger than 50 years of age.
METHODS:
We evaluated 5-year survival in a cohort of 423 gastric cancer patients using chronological age as a variable. Additionally, we assessed the protein expression of three molecules (COX-2, TFF1, Src) implicated in the pathogenesis of gastric cancer using immunohistochemistry.
RESULTS:
We found that patients younger than 50 years of age had a better 5-year survival rate in all tumor stages. We found that the expression of COX-2 and Src correlated significantly with survival in this group without any significant impact attributable to TFF1.
CONCLUSIONS:
Our study demonstrates that young gastric cancer patients have a better prognostic outlook that could in part be explained by the differential expression of COX-2 and Src.
AuthorsClaus Schildberg, M Abbas, S Merkel, A Agaimy, A Dimmler, A Schlabrakowski, R Croner, J Leupolt, W Hohenberger, H Allgayer
JournalJournal of surgical oncology (J Surg Oncol) Vol. 108 Issue 6 Pg. 409-13 (Nov 2013) ISSN: 1096-9098 [Electronic] United States
PMID24037722 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Wiley Periodicals, Inc.
Chemical References
  • Biomarkers, Tumor
  • TFF1 protein, human
  • Trefoil Factor-1
  • Tumor Suppressor Proteins
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Proto-Oncogene Proteins pp60(c-src)
Topics
  • Adult
  • Age Factors
  • Biomarkers, Tumor (analysis)
  • Carcinoma (chemistry, mortality, pathology, surgery)
  • Cyclooxygenase 2 (analysis)
  • Esophagogastric Junction
  • Female
  • Germany
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Proto-Oncogene Proteins pp60(c-src) (analysis)
  • Retrospective Studies
  • Stomach Neoplasms (chemistry, mortality, pathology, surgery)
  • Tissue Array Analysis
  • Trefoil Factor-1
  • Tumor Suppressor Proteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: